Document Detail

Predictions of survival up to 10 years after diagnosis for european women with breast cancer in 2000-2002.
MedLine Citation:
PMID:  23047687     Owner:  NLM     Status:  Publisher    
Few studies have addressed longer-term survival for breast cancer in European women. We have made predictions of ten-year survival for European women diagnosed with breast cancer in 2000-2002. Data for 114,312 adult women (15-99 years) diagnosed with a first primary malignant cancer of the breast during 2000-2002 were collected in the EUROCARE-4 study from 24 population-based cancer registries in 14 European countries. We estimated relative survival at one, five and ten years after diagnosis for women who were alive at some point during 2000-2002, using the period approach. We also estimated ten-year survival conditional on survival to one and five years after diagnosis. Ten-year survival exceeded 70% in most regions, but was only 54% in Eastern Europe, with the highest value in Northern Europe (about 75%). Ten-year survival conditional on survival for one year was 2%-6% higher than ten-year survival in all European regions, and geographic differences were smaller. Ten-year survival for women who survived at least five years was 88% overall, with the lowest figure in Eastern Europe (79%) and the highest in the UK (91%). Women aged 50-69 years had higher overall survival than older and younger women (79%). Six cancer registries had adequate information on stage at diagnosis; in these jurisdictions, 10-year survival was 89% for local, 62% for regional and 10% for metastatic disease. Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population-based survival, which provides vital information for improving breast cancer control. © 2012 Wiley Periodicals, Inc.
Claudia Allemani; Pamela Minicozzi; Franco Berrino; Esther Bastiaannet; Anna Gavin; Jaume Galceran; Alberto Ameijide; Sabine Siesling; Lucia Mangone; Eva Ardanaz; Guy Hédelin; Antonio Mateos; Andrea Micheli; Milena Sant;
Related Documents :
23014897 - Visualizing clinical predictors of febrile neutropenia in asian cancer patients receivi...
23682077 - How long will it take to reduce gastric cancer incidence by eradicating helicobacter py...
16477677 - Demographic and clinical predictors of preparatory grief in a sample of advanced cancer...
23519057 - Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and m...
14715107 - Trastuzumab regimens for her2-overexpressing metastatic breast cancer.
21869707 - Esophageal adenocarcinoma and hypertrophic osteoarthropathy with improvement following ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-10
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  -     ISSN:  1097-0215     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 UICC.
Analytical Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan Italy; Cancer Research UK Cancer Survival Group, Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Helium nanodroplets doped with xenon and rubidium atoms: a case study of van der Waals interactions ...
Next Document:  Quantitative Histopathological Assessment of Retardation of Islets of Langerhans Degeneration in Ros...